Indicators

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2 3 4 5 6 7 8 9

...

Price Over Earnings Overview: Sanofi

January 10, 2025

Sanofi's Blood Cancer Drug's New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma

January 09, 2025

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies

January 08, 2025

How Is The Market Feeling About Sanofi?

December 30, 2024

A Look Into Sanofi Inc's Price Over Earnings

December 25, 2024

Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?

December 22, 2024

Why Cytokinetics Stock Was a Nearly 5% Winner Today

December 20, 2024

Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases

December 18, 2024

RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday

December 17, 2024

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?

December 17, 2024

Sanofi's 340B Credit Proposal Draws Federal Warning For Statutory Violation

December 17, 2024

Kennedy's Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children

December 13, 2024

2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors

December 05, 2024

Jim Cramer: This Energy Stock Is A 'Winner,' But Navitas Semiconductor Is 'Losing A Lot Of Money'

December 04, 2024

Bird Flu Found In Raw Milk Leads To Recall In California

November 26, 2024

Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System

November 20, 2024

Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?

November 20, 2024

European And US Vaccine Stocks Are Under Pressure - Here's WHy

November 15, 2024

FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease

November 15, 2024

Viking Fund Management Sells Big Oil Stocks In Q3, Cuts Tesla Position In Half, Adds To Largest Position Broadcom

November 14, 2024

Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease

November 13, 2024

Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price

November 13, 2024

Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks

November 08, 2024

Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say

November 05, 2024

FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes

November 01, 2024

Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?

October 31, 2024

Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

October 28, 2024

Why Sanofi Stock Flew Higher on Friday

October 25, 2024

Sanofi (SNY) Q3 2024 Earnings Call Transcript

October 25, 2024

Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent

October 25, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.